Advertisement
Advertisement

OSUR

OSUR logo

OraSure Technologies Inc

4.00
USD
Sponsored
-0.05
-1.23%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

4.00

0.00
+0.12%

OraSure Technologies Inc Profile

About

OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.

Info & Links

CEO

Carrie Eglinton Manner

Headquarters

220 EAST FIRST STREET
BETHLEHEM, PA 18015, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.orasure.com

Auditor

GRANT THORNTON LLP

Share holders

241

Employees

500

OraSure Technologies Inc Statistics

Valuation Measures

Market Capitalization2

275.74M

Enterprise Value

115.36M

Enterprise Value/EBITDA(ttm)

-2.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.48

Price to Book(mrq)

0.88

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

31.68%

Operating Margin(ttm)

-56.63%

Profit Margin(ttm)

-50.71%

Return on Equity(ttm)

-19.09%

Return on Invested Capital(ttm)

-16.58%

Return on Assets(ttm)

-16.26%

Income Statement

Revenue(ttm)

112.41M

Revenue Per Share(ttm)

1.63

Gross Profit(ttm)

47.86M

EBITDA(ttm)3

-44.45M

Net Income Available to Common(ttm)

-49.13M

Diluted EPS(ttm)

-0.69

Share Statistics

Beta (5Y Monthly)

1.00

52-Week Change

43.88%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

68.97M

Dividend Yield

0.00%

Float4

65.61M

% Held by Insiders

4.70%

% Held by Institutions

93.50%

Balance Sheet

Total Cash(mrq)

160.58M

Total Cash Per Share(mrq)

2.33

Total Debt(mrq)

206.00K

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

7.68%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement